The metabolism of single and recurring once-everyday doses of CONCERTA® is analogous. Just after oral dosing of radiolabeled methylphenidate in individuals, about 90% in the radioactivity was recovered in urine. The most crucial urinary metabolite was PPAA, accounting for about 80% on the dose.Therefore, the FDA has improved the therapeutic equiva